IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Journal for ImmunoTherapy of Cancer- Impact Score, Overall Ranking, h-index, SJR, Rating, Publisher, ISSN, and Other Important Metrics

Last Updated on May 27, 2022

Impact Score

10.68

h-Index

 80

Rank

 475

SJR

 3.45

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics

Title Journal for ImmunoTherapy of Cancer
Abbreviation J. ImmunoTher. Cancer
Publication Type Journal
Subject Area, Categories, Scope Cancer Research (Q1); Immunology (Q1); Immunology and Allergy (Q1); Molecular Medicine (Q1); Oncology (Q1); Pharmacology (Q1)
h-index 80
Overall Rank/Ranking 475
SCImago Journal Rank (SJR) 3.45
Impact Score 10.68
Publisher BMJ Publishing Group
Country United Kingdom
ISSN 20511426




About Journal for ImmunoTherapy of Cancer


Journal for ImmunoTherapy of Cancer is a journal covering the technologies/fields/categories related to Cancer Research (Q1); Immunology (Q1); Immunology and Allergy (Q1); Molecular Medicine (Q1); Oncology (Q1); Pharmacology (Q1). It is published by BMJ Publishing Group. The overall rank of Journal for ImmunoTherapy of Cancer is 475. According to SCImago Journal Rank (SJR), this journal is ranked 3.45. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 80. The best quartile for this journal is Q1.

The ISSN of Journal for ImmunoTherapy of Cancer journal is 20511426. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Journal for ImmunoTherapy of Cancer is cited by a total of 11990 articles during the last 3 years (Preceding 2021).


Journal for ImmunoTherapy of Cancer Impact Score 2021-2022


The impact score (IS) 2021 of Journal for ImmunoTherapy of Cancer is 10.68, which is computed in 2022 as per its definition. Journal for ImmunoTherapy of Cancer IS is decreased by a factor of 0.69 and approximate percentage change is -6.07% when compared to preceding year 2020, which shows a falling trend. The impact score (IS), also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Journal for ImmunoTherapy of Cancer Impact Score 2022 Prediction


IS 2021 of Journal for ImmunoTherapy of Cancer is 10.68. If the same downward trend persists, impact score may fall in 2022 as well.


Impact Score Trend


Year wise Impact Score (IS) of Journal for ImmunoTherapy of Cancer. Based on Scopus data.


Year Impact Score (IS)
2022/2023 Coming Soon
2021 10.68
2020 11.37
2019 9.09
2018 7.76
2017 5.80
2016 5.11
2015 4.97
2014 2.24

Journal for ImmunoTherapy of Cancer h-index


  Table Setting

Journal for ImmunoTherapy of Cancer has an h-index of 80. It means 80 articles of this journal have more than 80 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Journal for ImmunoTherapy of Cancer ISSN


The ISSN of Journal for ImmunoTherapy of Cancer is 20511426. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Journal for ImmunoTherapy of Cancer Rank and SCImago Journal Rank (SJR)


The overall rank of Journal for ImmunoTherapy of Cancer is 475. According to SCImago Journal Rank (SJR), this journal is ranked 3.45. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Journal for ImmunoTherapy of Cancer Publisher


Table Setting

Journal for ImmunoTherapy of Cancer is published by BMJ Publishing Group. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2013-2021. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Journal for ImmunoTherapy of Cancer is J. ImmunoTher. Cancer. This abbreviation ('J. ImmunoTher. Cancer') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Journal for ImmunoTherapy of Cancer


If your research field is/are related to Cancer Research (Q1); Immunology (Q1); Immunology and Allergy (Q1); Molecular Medicine (Q1); Oncology (Q1); Pharmacology (Q1), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
European Surgical Research journal 11679 S. Karger AG 47 1.23
Archnet-IJAR journal 13809 Emerald Group Publishing Ltd. 16 0.97
Results in Mathematics journal 6370 Birkhauser Verlag Basel 36 1.35
Analyses of Social Issues and Public Policy journal 13530 Wiley-Blackwell Publishing Ltd 33 1.39
Artificial Intelligence Review journal 1083 Springer Netherlands 86 11.67
Clinical Laboratory journal 16089 Verlag Klinisches Labor GmbH 49 0.93
World Customs Journal journal 20849 International Network of Customs Universities 12 0.30
Ciencia e Agrotecnologia journal 10937 Federal University of Lavras 33 1.56
Historical Reflections journal 26652 Berghahn Journals 9 0.03
Studies on Neotropical Fauna and Environment journal 14354 Taylor and Francis Ltd. 34 1.05

Check complete list




Year wise Impact Score (IS) of Journal for ImmunoTherapy of Cancer

Impact Score Table

Year Impact Score (IS)
2022/2023 Coming Soon
2021 10.68
2020 11.37
2019 9.09
2018 7.76
2017 5.80
2016 5.11
2015 4.97
2014 2.24



Top Journals/Conferences in Cancer Research

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Journal of Clinical Oncology
American Society of Clinical Oncology | United States

JAMA Oncology
American Medical Association | United States

Cell Host and Microbe
Cell Press | United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

Journal of the National Cancer Institute
Oxford University Press | United Kingdom

Annual Review of Cancer Biology
Annual Reviews Inc. | United States

Clinical Cancer Research
American Association for Cancer Research Inc. | United States

Cancer Immunology Research
American Association for Cancer Research Inc. | United States

See All

Top Journals/Conferences in Immunology

Nature Reviews Immunology
Nature Publishing Group | United Kingdom

Annual Review of Immunology
Annual Reviews Inc. | United States

Immunity
Cell Press | United States

Nature Reviews Microbiology
Nature Publishing Group | United Kingdom

Clinical Microbiology Reviews
American Society for Microbiology | United States

Nature Immunology
Nature Publishing Group | United Kingdom

Science immunology
American Association for the Advancement of Science | United States

Molecular Systems Biology
Wiley-Blackwell | United States

Journal of Experimental Medicine
Rockefeller University Press | United States

Cell Host and Microbe
Cell Press | United States

See All

Top Journals/Conferences in Immunology and Allergy

Nature Reviews Immunology
Nature Publishing Group | United Kingdom

Annual Review of Immunology
Annual Reviews Inc. | United States

Immunity
Cell Press | United States

Nature Immunology
Nature Publishing Group | United Kingdom

Science immunology
American Association for the Advancement of Science | United States

Journal of Experimental Medicine
Rockefeller University Press | United States

Immunological Reviews
Wiley-Blackwell Publishing Ltd | United Kingdom

Trends in Immunology
Elsevier Ltd. | United Kingdom

Annals of the Rheumatic Diseases
BMJ Publishing Group | United Kingdom

Seminars in Immunopathology
Springer Verlag | Germany

See All

Top Journals/Conferences in Molecular Medicine

Nature Biotechnology
Nature Publishing Group | United Kingdom

Cell Stem Cell
Cell Press | United States

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

Genome Medicine
BioMed Central Ltd. | United Kingdom

EMBO Molecular Medicine
Wiley-Blackwell | United Kingdom

Molecular Therapy
Cell Press | United States

Trends in Molecular Medicine
Elsevier Ltd. | United Kingdom

Molecular Aspects of Medicine
Elsevier Ltd. | United Kingdom

Cell Chemical Biology
Elsevier Inc. | United States

See All

Top Journals/Conferences in Oncology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Lancet Oncology, The
Lancet Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Nature Reviews Clinical Oncology
Nature Publishing Group | United Kingdom

Journal of Clinical Oncology
American Society of Clinical Oncology | United States

JAMA Oncology
American Medical Association | United States

Annals of Oncology
Elsevier Ltd. | United Kingdom

Molecular Cancer
BioMed Central Ltd. | United Kingdom

Cancer Discovery
American Association for Cancer Research Inc. | United States

See All

Top Journals/Conferences in Pharmacology

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Annual Review of Pharmacology and Toxicology
Annual Reviews Inc. | United States

Drug Resistance Updates
Churchill Livingstone | United States

Trends in Pharmacological Sciences
Elsevier Ltd. | United Kingdom

Molecular Therapy
Cell Press | United States

Pharmacology and Therapeutics
Elsevier Inc. | United States

Cell Chemical Biology
Elsevier Inc. | United States

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

Cellular and Molecular Life Sciences
Birkhauser Verlag Basel | Switzerland

See All